Ibudilast suppresses oxaliplatin-induced mechanical allodynia and neurodegeneration in rats
Oxaliplatin is a key drug used in the management of solid tumors, such as colorectal cancer; however, it causes peripheral neuropathy. In this study, we investigated the effect of ibudilast, a phosphodiesterase inhibitor, on oxaliplatin-induced mechanical allodynia and histological changes in rats....
Main Authors: | Nobuaki Egashira, Yu Goto, Ryota Takahashi, Hikari Iba, Shota Yamamoto, Takuya Watanabe, Kaori Kubota, Takehiro Kawashiri, Chise Taniguchi, Shutaro Katsurabayashi, Katsunori Iwasaki |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Journal of Pharmacological Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861321000608 |
Similar Items
-
Ibudilast: a non-selective phosphodiesterase inhibitor in brain disorders
by: Joanna Schwenkgrub, et al.
Published: (2017-03-01) -
Role of phosphodiesterase inhibitor Ibudilast in morphine-induced hippocampal injury
by: Mohsen Zhaleh, et al.
Published: (2014-07-01) -
A double-blind, randomized, placebo-controlled pilot trial to determine the efficacy and safety of ibudilast, a potential glial attenuator, in chronic migraine
by: Kwok YH, et al.
Published: (2016-10-01) -
Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial
by: Elizabeth M. Burnette, et al.
Published: (2020-09-01) -
Ibudilast (MN-166) in amyotrophic lateral sclerosis- an open label, safety and pharmacodynamic trial
by: Suma Babu, et al.
Published: (2021-01-01)